| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.089 | 0.06 |